Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Tempus Priority Study: A Pan-tumor Observational Study

← catalyst calendar

NCT05179824 · readout in 61 d

Sponsored by Tempus AI (industry) · TEM — their whole pipeline →.

Phase
Status
Active, not recruiting
Study type
Observational
Enrollment
1,000estimated
Sites
2
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2020-10-19actualWhen the study began enrolling
Primary completion2026-10-19estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2030-10-19estimatedThe whole study's end, after follow-up
First posted2022-01-05actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-05-06actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Breast Cancer
  • Prostate Cancer
  • Bladder Cancer
  • Lung Cancer
  • Brain Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer
  • Cancer of Liver
  • Cancer of Colon
  • Cancer of Head and Neck
  • Cancer of Stomach
  • Cancer of Gastrointestinal Tract
  • Cancer of Rectum
  • Cancer of Esophagus
  • Cancer of Skin
  • Cancer of Cervix
  • Cancer of Kidney
  • Cancer of Larynx
  • Cancer of Endometrium
  • Cancer of the Bile Duct
  • Cancer of Vulva
  • Cancer of Bone and Connective Tissue
  • Leukemia
  • Lymphoma
  • Spinal Cord Cancer

Intervention

  • Other: Observation

Primary outcome

what the primary-completion date above is the date OF
Create robust data set of health information
measured Up to 10 years

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · TEM's whole pipeline · Catalyst calendar · Every registered study · What changed